News

Zenith Healthcare Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the announcement of its unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with SEBI regulations.

Zenith Healthcare Limited informed the BSE Limited that Mr. Akshit M. Raycha (DIN: 03039859) has been regularized as Joint Managing Director/Whole Time Director at the company`s 32nd Annual General Meeting via a special resolution. The appointment, initially made on May 29, 2026, will continue until the conclusion of the next AGM, with a monthly remuneration of up to Rs 200,000, potentially increasing by Rs 900,000 per annum.

Zenith Healthcare Limited announced that Mr. Mahendra C. Raycha has been re-appointed as Managing Director for another three-year term, from July 1, 2026, to June 30, 2029, following a special resolution at the company’s 32nd Annual General Meeting. Mr. Raycha, who holds 6,604,000 equity shares, representing 12.29% voting power, was re-appointed due to attaining the age of 70 years, and his continued experience is deemed vital for the company`s future growth.

Zenith Health Care will hold a meeting of the Board of Directors of the Company on 14 August 2026.

Zenith Health Care announced that the 32nd Annual General Meeting(AGM) of the company will be held on 28 August 2026.